Ozempic, Wegovy, and GLP-1 Medications: Can You Still Become a Surrogate?

GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have helped millions of people reach a healthier weight. If you’ve used one of these drugs and are now considering gestational surrogacy, you’re probably wondering whether your medication history affects your eligibility. The short answer is that GLP-1 use doesn’t automatically disqualify you — but there are important timelines, health benchmarks, and disclosure requirements you need to understand before you apply.

This guide covers everything you need to know about GLP-1 medications and surrogacy eligibility, from mandatory washout periods to what clinics are actually looking for during screening.

What Are GLP-1 Medications?

GLP-1 receptor agonists (glucagon-like peptide-1) are a class of injectable medications originally developed for type 2 diabetes management. Drugs like semaglutide (sold as Ozempic for diabetes and Wegovy for weight management) and tirzepatide (Mounjaro and Zepbound) work by mimicking a hormone that regulates appetite and blood sugar. The result is significant weight loss for many users — often 15 to 25 percent of body weight over a year.

Because these medications are relatively new in widespread use, fertility clinics and surrogacy agencies are still developing their policies around them. However, a clear consensus has emerged on several key points.

Why GLP-1 Medications Must Be Stopped Before Surrogacy

GLP-1 medications are not approved for use during pregnancy. The FDA categorizes them with warnings about potential risks to a developing fetus, and no fertility clinic will proceed with an embryo transfer while a surrogate is actively taking one. The primary concerns include:

Unknown fetal effects. While animal studies have raised some concerns about fetal development, human data is limited precisely because pregnant women are excluded from clinical trials. No responsible clinic will take that risk with a surrogacy pregnancy.

Appetite and nutrition. GLP-1 drugs work partly by slowing gastric emptying and reducing appetite. During pregnancy, adequate caloric intake and proper nutrition are essential for healthy fetal development. A medication that suppresses appetite could interfere with the increased nutritional demands of pregnancy.

Nausea and gastrointestinal effects. These medications commonly cause nausea, vomiting, and other GI side effects. Combined with the nausea that often accompanies the first trimester of pregnancy, this could create serious problems with keeping food and prenatal vitamins down.

Anesthesia considerations. GLP-1 drugs slow stomach emptying, which can increase aspiration risk during any procedure requiring sedation or anesthesia — including a potential C-section delivery.

The Washout Period: How Long Before You Can Transfer

Every IVF clinic sets its own washout requirement, but most ask surrogates to be completely off GLP-1 medications for a minimum of two months before beginning the transfer medication protocol. Some clinics require longer — up to three or even six months — depending on which specific drug you were taking and how long you were on it.

The washout period serves several purposes. First, the medication needs to be fully cleared from your system. Semaglutide, for example, has a half-life of about one week, meaning it takes roughly five to seven weeks for the drug to be essentially eliminated from your body. Tirzepatide has a similar timeline. Second, the clinic wants to see that your weight and metabolic markers are stable without the medication before they invest in a transfer cycle.

Here’s what the timeline typically looks like:

1. Decision to stop: You and your prescribing doctor agree on a plan to discontinue the GLP-1 medication.
2. Washout period: Minimum two months off the drug completely, with some clinics requiring longer.
3. Weight stabilization: Your weight needs to remain stable (not actively dropping) for the duration of the washout period.
4. Application and screening: Once you’ve been off the medication long enough, you proceed with the normal surrogacy application and medical screening process.
5. Medical clearance: The fertility clinic reviews your labs, weight stability, and overall health before giving you the green light.

If you’re currently on a GLP-1 medication and thinking about surrogacy, start the discontinuation conversation with your doctor well in advance. Don’t stop the medication abruptly without medical guidance, especially if you’re taking it for diabetes management.

BMI Requirements and Weight Stability

One of the most common reasons women use GLP-1 medications before pursuing surrogacy is to bring their BMI into the eligible range. Most surrogacy agencies and IVF clinics require a BMI between roughly 19 and 33, though the exact cutoff varies by program. If a GLP-1 medication helped you reach that range, the weight loss itself is generally viewed positively — you’ve taken proactive steps to improve your health.

However, clinics are looking for more than just a number on the scale. They want to see:

Weight stability. Your weight should be holding steady at your current level, not actively declining. A surrogate whose weight is still dropping month over month raises concerns about whether she can maintain adequate nutrition during pregnancy and whether her weight might rebound once pregnancy hormones enter the picture.

Sustainable habits. Clinics want evidence that your current weight is maintainable without the medication. Have you adopted the dietary and lifestyle changes that will keep you in a healthy range throughout a pregnancy? This isn’t a judgment — it’s a practical health consideration.

Normal metabolic markers. Blood sugar, A1C, and other metabolic labs should be within normal ranges off the medication. If you were taking a GLP-1 drug for type 2 diabetes rather than weight management alone, the clinic will pay special attention to whether your blood sugar remains controlled without it.

Some women worry about weight regain after stopping GLP-1 medications, and that concern is valid — studies show that many people regain some weight after discontinuation. If your weight creeps back above the BMI cutoff after stopping the drug, that could delay or complicate your surrogacy plans. Talk honestly with your doctor about a sustainable plan for maintaining your weight through the washout period and a potential pregnancy.

Full Disclosure During Screening

If you’ve used a GLP-1 medication at any point, you must disclose this during your surrogacy application and medical screening. This is non-negotiable, and there are several good reasons to be completely upfront about it.

They’ll likely find out anyway. Medical screening for surrogacy involves comprehensive bloodwork and a thorough review of your health history. Concealing medication use could show up in lab results or come to light through pharmacy records, and dishonesty at the screening stage is grounds for immediate disqualification from any reputable program.

Disclosure protects you. The screening process exists to ensure that carrying a pregnancy is safe for you. If a clinic doesn’t know your full medication history, they can’t make an accurate assessment of your health risks. You deserve a medical team that has complete information.

It’s usually not a deal-breaker. Clinics are seeing more and more applicants with GLP-1 histories, and most have straightforward protocols for evaluating these candidates. Being honest about your medication use signals maturity and responsibility — exactly the qualities agencies look for in a surrogate.

When you disclose, be prepared to share: which specific medication you took, the dosage, how long you were on it, when you stopped, why you were taking it (weight management versus diabetes), and how your weight has trended since discontinuation.

What If You Were Taking GLP-1 for Diabetes?

There’s an important distinction between using a GLP-1 medication for weight management and using it for type 2 diabetes. If Ozempic or a similar drug was prescribed to manage your blood sugar, the clinic’s evaluation will be more involved.

The key question is whether your blood sugar remains well-controlled without the medication. If you’ve been able to maintain normal glucose levels and a healthy A1C through diet and exercise after discontinuing the GLP-1, many clinics will still consider you. If your diabetes is not well-controlled off medication, or if you need to switch to another diabetes drug that also isn’t pregnancy-safe, that presents a more complex situation.

Gestational diabetes is already a common concern in surrogate pregnancies, and a history of type 2 diabetes significantly increases that risk. Your fertility doctor and an endocrinologist may need to coordinate on a plan that keeps your blood sugar managed safely throughout the pregnancy. This is possible, but it requires more monitoring and planning than a straightforward case.

How to Prepare for Surrogacy After GLP-1 Use

If you’re currently on a GLP-1 medication and planning to pursue surrogacy, here’s a practical roadmap:

Talk to your prescribing doctor first. Explain your surrogacy plans and work out a discontinuation timeline. Your doctor may want to taper the dose gradually rather than stopping cold.

Start the washout early. Given that most clinics want at least two months off the medication, and the surrogacy application and matching process takes additional time, plan to stop the medication well before you expect to be matched and ready for transfer.

Focus on sustainable habits. Use the washout period to solidify the eating and exercise patterns that will support your health during pregnancy. This is the time to prove — to yourself and to the clinic — that your current weight is sustainable.

Document your weight trajectory. Keep a simple log of your weight from the time you stop the medication through your screening. A stable, documented weight trend will give the clinic confidence.

Get your labs done proactively. If possible, have your primary care doctor run a metabolic panel (fasting glucose, A1C, lipids) a few weeks before your surrogacy screening so you know where you stand.

Be patient with the timeline. GLP-1 use may add a few months to your overall surrogacy timeline, but those months are an investment in a safe and healthy pregnancy.

Common Questions

Can I restart the GLP-1 medication after delivery? Yes. Once you’ve delivered and completed any postpartum recovery (and breast milk pumping, if applicable), you can discuss resuming the medication with your doctor. Many surrogates plan for this and it doesn’t affect the surrogacy journey.

What if I just started the medication recently? A shorter duration of use generally means a simpler washout. If you’ve only been on the medication for a few weeks or months, the transition off should be straightforward, and the washout period may be on the shorter end of the two-to-six month range.

Will the agency judge me for using weight loss medication? Reputable agencies don’t judge applicants for their health decisions. What matters is your current health status and whether you meet the eligibility criteria at the time of screening. Using a medication to improve your health is a responsible choice, not a red flag.

Can I use a GLP-1 medication between surrogate pregnancies? If you’re planning a repeat journey, discuss the timing with your agency and clinic. You’d need to go through the full washout and restabilization process again before another transfer.

The Bottom Line

GLP-1 medications and gestational surrogacy are absolutely compatible — you just can’t do them at the same time. If you’ve used Ozempic, Wegovy, Mounjaro, or a similar drug to reach a healthier weight, that accomplishment can actually work in your favor during the screening process. The critical steps are stopping the medication with enough lead time, allowing your body to stabilize, being transparent about your history, and demonstrating that you’re in good health to carry a pregnancy.

Surrogacy programs are adapting to the reality that GLP-1 medications are now a common part of many women’s health histories. As long as you plan ahead and communicate openly, your medication history should not stand between you and a successful surrogacy journey.

Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice. Consult qualified professionals before making decisions about surrogacy.